Allergan Inc et al v. Valeant Pharmaceuticals International Inc et al

  1. April 09, 2015

    Valeant, Pershing End Spat With Allergan Over Takeover Bid

    Valeant Pharmaceuticals International Inc. and William Ackman's Pershing Square Capital Management LP hedge fund agreed Thursday to bury the hatchet with Allergan Inc. after the sides lobbed damages claims at one other tied to Valeant and Pershing's failed bid to buy the Botox maker in a $55 billion hostile takeover.

  2. November 14, 2014

    Valeant Disclosures Approved In Allergan Inside Trading Row

    A California federal court Friday implemented an order that Valeant Pharmaceuticals International Inc. and Bill Ackman's hedge fund make additional disclosures regarding Allergan Inc.'s insider trading suit, setting the stage for a special shareholder meeting next month that could decide the fate of their hostile takeover bid.

  3. November 13, 2014

    Allergan Slams Proposed Disclosures In Insider Trading Suit

    Allergan Inc. on Tuesday objected to Valeant Pharmaceuticals International Inc. and Bill Ackman's proposed set of disclosures to comply with a California federal court ruling that said they must address "serious questions" as to whether their joint hostile bid for Allergan violated insider trading laws.

  4. November 04, 2014

    Ackman Can Vote Allergan Shares Amid Insider Trading Flap

    A California federal judge said Tuesday that Allergan Inc. raised "serious questions" about whether Valeant Pharmaceuticals International Inc. and Bill Ackman had violated insider trading rules to lob a joint takeover bid but didn't block the famed activist from voting his sizable stake at a shareholder meeting next month.

  5. October 28, 2014

    Allergan Says Ackman's Valeant Vote Would 'Gut' Protections

    Allergan Inc. on Tuesday urged a California federal judge to block activist investor Bill Ackman from participating in a shareholder vote on a board overhaul that could enable a $53 billion takeover by Valeant Pharmaceuticals International Inc., arguing investor protections would be "gutted" if Ackman gets his way.

  6. October 27, 2014

    Allergan Decries Ackman's Smear Campaign Allegations

    Allergan Inc. on Sunday brushed off allegations that its executive masterminded a smear campaign to sour investors on wannabe buyer Valeant Pharmaceuticals International Inc., telling a California federal court the accusations have more to do with Valeant's public relations strategy than facts.

  7. October 21, 2014

    Ackman Says Allergan CEO Oversaw Valeant Smear Campaign

    Activist investor Bill Ackman in a new court filing late on Monday accused Allergan Inc.'s CEO of trying to tarnish Valeant Pharmaceuticals International Inc. in an effort to sour shareholders on its hostile $53 billion bid.

  8. October 07, 2014

    Allergan Aims To Block Ackman From Voting Stock At Meeting

    Allergan Inc. asked a judge overnight Monday to block Bill Ackman from participating in a shareholder vote on a board overhaul that could pave the way for a $53 billion takeover by Valeant Pharmaceuticals International Inc. supported by the activist investor.

  9. September 22, 2014

    Valeant Wins Access To Allergan Docs In Insider Trading Row

    A California federal judge on Monday ordered Allergan Inc. to fork over hundreds of pages of unredacted documents as part of its insider trading suit to Valeant Pharmaceuticals International Inc., which is accusing the Botox maker of lying to its shareholders amid Valeant's attempted $53 billion hostile takeover.

  10. September 19, 2014

    Allergan Defends Redactions In Valeant Insider Trading Suit

    Allergan Inc. on Thursday asked a California federal court to reject Valeant Pharmaceuticals International Inc.'s attempts to bar it from redacting documents in its insider trading suit against Valeant, saying its rival only wants the documents to help a $53 billion hostile takeover bid. 

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!